BAX
Baxter International Inc
NYSE: BAX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$17.53
+0.16% today
Updated 2026-06-05
Market cap
$10.87B
P/E ratio
—
P/S ratio
0.96x
EPS (TTM)
$-1.91
Dividend yield
1.79%
52W range
$16 – $31
Volume
7.3M
Baxter International Inc (BAX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.53
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$45.77
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $12.1B | $10.1B | $10.4B | $10.6B | $11.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -9.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.